Last update 15 Dec 2025

CDBN-YGXZ

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
CDBN-YGXZ
Target
PFOR
Action
inhibitors
Mechanism
PFOR inhibitors(Pyruvate synthase inhibitors)
Therapeutic Areas
Infectious Diseases
Active Indication
Clostridium difficile infection
Inactive Indication-
Originator Organization
Chengdu Biobel Biotechnology Co., Ltd
Active Organization
Chengdu Biobel Biotechnology Co., LtdChengdu Medical CollegeChengdu Medical College
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC22H29N3O5S
InChIKeyAMUUEJUHIOLNDW-UHFFFAOYSA-N
CAS Registry2762570-56-7

Related

100 Clinical Results associated with CDBN-YGXZ
Login to view more data
100 Translational Medicine associated with CDBN-YGXZ
Login to view more data
100 Patents (Medical) associated with CDBN-YGXZ
Login to view more data
2
Literatures (Medical) associated with CDBN-YGXZ
01 Jun 2025ANAEROBE
CDBN-YGXZ shows highly antibacterial activity against Clostridioides difficile as a potential candidate drug
17 May 2023Antimicrobial agents and chemotherapy
CDBN-YGXZ, a Novel Small-Molecule Drug, Shows Efficacy against Clostridioides difficile Infection and Recurrence in Mouse and Hamster Infection Models
100 Deals associated with CDBN-YGXZ
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Clostridium difficile infectionPreclinical
China
Chengdu Biobel Biotechnology Co., Ltd
13 Apr 2023
Clostridium difficile infectionPreclinical
China
Chengdu Medical CollegeChengdu Medical College
13 Apr 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free